Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer

NCT01394211 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT01394211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01394211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer
Lead sponsor
University of Arizona
Phase
Phase 2
Overall status
Terminated
Start date
July 13, 2011
Completion date
April 12, 2012
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

estrogen receptor-positive breast cancer, human epidermal growth factor 2 negative carcinoma of breast, male breast cancer, recurrent breast cancer, stage ii breast cancer, stage iiia breast cancer, stage iiib breast cancer